Company intelligence / Profile preview

VITAS Healthcare

Miramar, Florida, USA

Ownership: Private
Employees: ~12000
Development stage: Other

Overview

VITAS Healthcare is the largest single-source provider of hospice and palliative care in the US, serving over 22,000 patients daily with a team of more than 12,000 professionals. The company provides comprehensive end-of-life care primarily in patients' homes but also operates inpatient hospice units and partners with hospitals, nursing homes, and assisted living communities. VITAS supported the establishment of the Medicare Hospice Benefit and focuses on comfort, dignity, and support for patients and families. The company has received multiple awards for employee engagement and healthcare innovation, including being named a 2025 Top Workplace in Healthcare[1][5].

Therapeutic areas: Other
Modalities: Non-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

HealthGridAmerican Heart Association

Beyond the preview

Go deeper on VITAS Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VITAS Healthcare.

Explore the full profile